SecBot SecBot
SECBOTREPLAY Home › Report › PAHC

PAHC · Phibro Animal Health disclosed a Brazilian regulatory ban on…

PHIBRO ANIMAL HEALTH CORP · 8-K filed Apr 27, 2026 at 16:43 ET

At the news

BEARISHIMPACT 5/10

8-K filed Apr 27, 2026 at 16:43 ET

Phibro Animal Health disclosed a Brazilian regulatory ban on antimicrobial growth promoters including its virginiamycin and bacitracin products, effective after a 180-day transition period. The company expects limited FY2026 impact and is pursuing therapeutic registrations to mitigate long-term effects.

  • Brazilian MAPA Ordinance No. 1617 prohibits use of virginiamycin and bacitracin as growth promoters effective 180 days from April 27, 2026.
  • During transition period, sales and use under current labels continue.
  • Phibro expects limited impact on fiscal year 2026 results.
  • New registrations for therapeutic use of virginiamycin in cattle and broiler chickens are in final MAPA review and expected during transition.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access